Related references
Note: Only part of the references are listed.2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice guidelines
Thom W. Rooke et al.
CIRCULATION (2011)
The Importance of Population-Wide Sodium Reduction as a Means to Prevent Cardiovascular Disease and Stroke A Call to Action From the American Heart Association
Lawrence J. Appel et al.
CIRCULATION (2011)
Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update
Lori Mosca et al.
CIRCULATION (2011)
Heart Disease and Stroke Statistics-2011 Update A Report From the American Heart Association
Veronique L. Roger et al.
CIRCULATION (2011)
Comment on: American Diabetes Association. Standards of medical care in diabetes-2011 (vol 34, pg e53, 2011)
V Basevi et al.
DIABETES CARE (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Karen L. Furie et al.
STROKE (2011)
Standards of Medical Care in Diabetes-2011 AMERICAN DIABETES ASSOCIATION
DIABETES CARE (2011)
Optimizing Statin Treatment for Primary Prevention of Coronary Artery Disease
Rodney A. Hayward et al.
ANNALS OF INTERNAL MEDICINE (2010)
Waist Circumference and All-Cause Mortality in a Large US Cohort
Eric J. Jacobs et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Myocardial Infarction and Risk of Suicide A Population-Based Case-Control Study
Karen Kjaer Larsen et al.
CIRCULATION (2010)
Thiazolidinedione Drugs and Cardiovascular Risks A Science Advisory From the American Heart Association and American College of Cardiology Foundation
Sanjay Kaul et al.
CIRCULATION (2010)
Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged Men
Johan Arnlov et al.
CIRCULATION (2010)
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction The American Heart Association's Strategic Impact Goal Through 2020 and Beyond
Donald M. Lloyd-Jones et al.
CIRCULATION (2010)
Relationship Between Cardiac Rehabilitation and Long-Term Risks of Death and Myocardial Infarction Among Elderly Medicare Beneficiaries
Bradley G. Hammill et al.
CIRCULATION (2010)
A meta-analysis of randomized control trials of home-based secondary prevention programs for coronary artery disease
Alexander M. Clark et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2010)
Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial Index A Randomized Controlled Trial
F. Gerald R. Fowkes et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
Craig J. Currie et al.
LANCET (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Systematic Review: Glucose Control and Cardiovascular Disease in Type 2 Diabetes
Tanika N. Kelly et al.
ANNALS OF INTERNAL MEDICINE (2009)
Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding
Steven R. Steinhubl et al.
ANNALS OF INTERNAL MEDICINE (2009)
Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement
ANNALS OF INTERNAL MEDICINE (2009)
Exercise Training for Type 2 Diabetes Mellitus Impact on Cardiovascular Risk A Scientific Statement From the American Heart Association
Thomas H. Marwick et al.
CIRCULATION (2009)
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association
Jay S. Skyler et al.
CIRCULATION (2009)
Intensive glucose control and macrovascular outcomes in type 2 diabetes
F. M. Turnbull et al.
DIABETOLOGIA (2009)
Treadmill Exercise and Resistance Training in Patients With Peripheral Arterial Disease With and Without Intermittent Claudication A Randomized Controlled Trial
Mary M. McDermott et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Telephone-Delivered Collaborative Care for Treating Post-CABG Depression A Randomized Controlled Trial
Bruce L. Rollman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Aspirin for the Prevention of Cardiovascular Events in Patients With Peripheral Artery Disease A Meta-analysis of Randomized Trials
Jeffrey S. Berger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure HF-ACTION Randomized Controlled Trial
Christopher M. O'Connor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Routine Screening for Depression in Patients With Coronary Heart Disease Never Mind
Roy C. Ziegelstein et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Reduction in Recurrent Cardiovascular Events With Intensive Lipid-Lowering Statin Therapy Compared With Moderate Lipid-Lowering Statin Therapy After Acute Coronary Syndromes From the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Trial
Sabina A. Murphy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Meta-Analysis of the Relationship Between Non-High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
Jennifer G. Robinson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss
Carl J. Lavie et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
LANCET (2009)
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
Gilles Montalescot et al.
LANCET (2009)
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
Kausik K. Ray et al.
LANCET (2009)
Cytochrome P-450 Polymorphisms and Response to Clopidogrel.
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Effect on cessation counseling of documenting smoking status as a routine vital sign: An ACORN study
Stephen F. Rothemich et al.
ANNALS OF FAMILY MEDICINE (2008)
Systematic review: Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension
David B. Matchar et al.
ANNALS OF INTERNAL MEDICINE (2008)
Meta-analysis: Effect of monotherapy and combination therapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease
Regina Kunz et al.
ANNALS OF INTERNAL MEDICINE (2008)
Cardiovascular Outcomes in Trials of Oral Diabetes Medications - A Systematic Review
Elizabeth Selvin et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
The primary and secondary prevention of coronary artery disease
Richard C. Becker et al.
CHEST (2008)
Obesity, behavioral lifestyle factors, and risk of acute coronary events
Majken K. Jensen et al.
CIRCULATION (2008)
Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study
Andrzej Ciszewski et al.
EUROPEAN HEART JOURNAL (2008)
Regular exercise training compared with percutaneous intervention leads to a reduction of inflammatory markers and cardiovascular events in patients with coronary artery disease
Claudia Walther et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2008)
Depression Screening and Patient Outcomes in Cardiovascular Care A Systematic Review
Brett D. Thombs et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions
Somjot S. Brar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial
S. Yusuf et al.
LANCET (2008)
Telmisartan, ramipril, or both in patients at high risk for vascular events
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
Ralph L. Sacco et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
10-year follow-up of intensive glucose control in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack
Robert J. Adams et al.
STROKE (2008)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services
Randal J. Thomas et al.
CIRCULATION (2007)
Safety and efficacy of atorvastatin-induced very low-density lipoprotein cholesterol levels in patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study)
John C. LaRosa et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Physical activity and public health - Updated recommendation for adults from the American college of sports medicine and the American heart association
William L. Haskell et al.
CIRCULATION (2007)
Resistance exercise in individuals with and without cardiovascular disease: 2007 update - A scientific statement from the American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism
Mark A. Williams et al.
CIRCULATION (2007)
Core components of cardiac rehabilitation/secondary prevention programs: 2007 update - A scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation
Gary J. Balady et al.
CIRCULATION (2007)
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial
Deepak L. Bhatt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease:: randomized, double-blind trial
E. Pilger et al.
JOURNAL OF INTERNAL MEDICINE (2007)
Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial
P. H. A. Halkes et al.
LANCET NEUROLOGY (2007)
Influenza vaccination as secondary prevention for cardiovascular disease - A science advisory from the American Heart Association/American College of Cardiology
Matthew M. Davis et al.
CIRCULATION (2006)
ACC/AHA 2006 guidelines for the management of patients with valvular heart disease
Robert O. Bonow et al.
CIRCULATION (2006)
Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy
Christopher P. Cannon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update - Endorsed by the National Heart, Lung, and Blood Institute
Sidney C. Smith et al.
CIRCULATION (2006)
Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure
C Passino et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
DL Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic) - A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery,* Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease)
AT Hirsch et al.
CIRCULATION (2006)
High-dose atorvastatin vs usual dose simvastatin for secondary prevention after myocardial infarction - The IDEAL study: A randomized controlled trial
TR Pedersen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial
ZM Chen et al.
LANCET (2005)
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study):: randomised controlled trial
A Keech et al.
LANCET (2005)
Meta-analysis: Secondary prevention programs for patients with coronary artery disease
AM Clark et al.
ANNALS OF INTERNAL MEDICINE (2005)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
Analysis of risk of bleeding complications after different doses of Aspirin in 192,036 patients enrolled in 31 randomized controlled trials
VL Serebruany et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
JC LaRosa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The effects of a smoking cessation intervention on 14.5-year mortality - A randomized clinical trial
NR Anthonisen et al.
ANNALS OF INTERNAL MEDICINE (2005)
Cardiac rehabilitation and secondary prevention of coronary heart disease - An American Heart Association Scientific Statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in collaboration with the American Association of Cardiovascular and Pulmonary Rehabilitation
AS Leon et al.
CIRCULATION (2005)
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
CP Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease -: A randomized trial
R Hambrecht et al.
CIRCULATION (2004)
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
SM Grundy et al.
CIRCULATION (2004)
Clinical implications of obesity with specific focus on cardiovascular disease - A statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism - Endorsed by the American College of Cardiology Foundation
S Klein et al.
CIRCULATION (2004)
Flu vaccination in acute coronary syndromes and planned percutaneous (FLUVACS) study - One-year follow-up
EP Gurfinkel et al.
EUROPEAN HEART JOURNAL (2004)
Task force 1: The ACCF and AHA codes of conduct in human subjects research
RJ Adams et al.
CIRCULATION (2004)
Exercise-based rehabilitation for patients with coronary heart disease: Systematic review and meta-analysis of randomized controlled trials
RS Taylor et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation
T Kavanagh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
AV Chobanian et al.
HYPERTENSION (2003)
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
MA Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A comparative analysis of the results from 4 trials of β-blocker therapy for heart failure:: BEST, CIBIS-II, MERIT-HF, and COPERNICUS
MJ Domanski et al.
JOURNAL OF CARDIAC FAILURE (2003)
Effects of candesartan on mortality and morbidity in patients with chronic heart failure:: the CHARM-Overall programme
MA Pfeffer et al.
LANCET (2003)
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol, European Trial (COMET): randomised controlled trial
PA Poole-Wilson et al.
LANCET (2003)
Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease -: A statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity)
PD Thompson et al.
CIRCULATION (2003)
Insulin resistance and cardiovascular events with low HDL cholesterol - The Veterans Affairs HDL Intervention Trial (VA-HIT)
SJ Robins et al.
DIABETES CARE (2003)
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial
PS Sever et al.
LANCET (2003)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Oral anticoagulants in patients with coronary artery disease
SS Anand et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - Summary article - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Chronic Stable Angina)
RJ Gibbons et al.
CIRCULATION (2003)
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report
SM Grundy et al.
CIRCULATION (2002)
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
J Shepherd et al.
LANCET (2002)
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention - A randomized controlled trial
SR Steinhubl et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease
PM Kris-Etherton et al.
CIRCULATION (2002)
Aspirin and mortality from coronary bypass surgery
DT Mangano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Warfarin, aspirin, or both after myocardial infarction.
M Hurlen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Prediction of long-term prognosis in 12 169 men referred for cardiac rehabilitation
T Kavanagh et al.
CIRCULATION (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Effect of aerobic exercise on blood pressure: A meta-analysis of randomized, controlled trials
SP Whelton et al.
ANNALS OF INTERNAL MEDICINE (2002)
The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: The obesity paradox?
L Gruberg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
N-3 polyunsaturated fatty acids in coronary heart disease: A meta-analysis of randomized controlled trials
HC Bucher et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
BG Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke
JP Mohr et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
SR Mehta et al.
LANCET (2001)
Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet.
FM Sacks et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II
B Pitt et al.
LANCET (2000)
Share Paper
